PCG
58
-3
MO
51
-2
PPL
47
-2
VNO
56
-3
CF
56
3
SPG
51
-5
KEY
31
-2
KHC
18
-2
DVN
18
-3
QCOM
51
-5
BLK
67
4
AAL
62
3
GILD
54
4
ORCL
59
-3
GIS
37
3
DG
27
4
KSS
26
-2
MAS
56
-6
UA
53
-3
CAT
58
-4
PCG
58
-3
MO
51
-2
PPL
47
-2
VNO
56
-3
CF
56
3
SPG
51
-5
KEY
31
-2
KHC
18
-2
DVN
18
-3
QCOM
51
-5
BLK
67
4
AAL
62
3
GILD
54
4
ORCL
59
-3
GIS
37
3
DG
27
4
KSS
26
-2
MAS
56
-6
UA
53
-3
CAT
58
-4
Financhill
Back

Herzfeld Caribbean Basin Fund Vs. Aligos Therapeutics Industry Stock Comparison

Sell
48

CUBA
Herzfeld Caribbean Basin Fund

Last Price:
2.48
Seasonality Move:
3.13%
Buy
74

ALGS
Aligos Therapeutics

Last Price:
34.48
Seasonality Move:
10.65%
Sell
48
Herzfeld Caribbean Basin Fund (CUBA) is a Sell

Is Herzfeld Caribbean Basin Fund a Buy, Sell or Hold?

  • The current Herzfeld Caribbean Basin Fund [CUBA] share price is $2.44. The Score for CUBA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CUBA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $30.82. The Score for ALGS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CUBA Stock Price Chart

What is Herzfeld Caribbean Basin Fund's stock price today?

  • The Herzfeld Caribbean Basin Fund share price today is $2.44
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CUBA is experiencing selling pressure, which indicates risk of future bearish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $30.82
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

CUBA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 50.45 Buy
Chaikin Money Flow: -8010 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.42 - 2.5) Sell
Bollinger Bands (100): (2.26 - 2.44) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.32 Buy
Relative Strength Index (14 RSI): 81.62 Buy
Chaikin Money Flow: 315379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.3 - 26.46) Buy
Bollinger Bands (100): (7.85 - 19.03) Buy

CUBA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.45 Sell
20-day SMA: 2.45 Sell
50-day SMA: 2.41 Buy
200-day SMA: 2.42 Buy
8-day EMA: 2.45 Sell
20-day EMA: 2.45 Sell
50-day EMA: 2.41 Buy
200-day EMA: 2.49 Sell

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.35 Buy
20-day SMA: 22.81 Buy
50-day SMA: 14.24 Buy
200-day SMA: 15.81 Buy
8-day EMA: 27.13 Buy
20-day EMA: 22.88 Buy
50-day EMA: 17.49 Buy
200-day EMA: 15.94 Buy

Herzfeld Caribbean Basin Fund Earnings Growth & CUBA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Herzfeld Caribbean Basin Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):